Millipore Acquires NovAseptic AB: Broadens Offering to Biotech and Pharmaceutical Industry
Martin Madaus, Millipore's Chairman, CEO and President, noted: "NovAseptic brings innovative and differentiated products that our biotech and pharmaceutical customers value highly for manufacturing biologics and for monitoring bio-manufacturing processes. There is a great fit strategically and tactically, and we've added exceptional technology and talent to Millipore."
NovAseptic, based in Gothenburg, Sweden, provides a range of innovative solutions for aseptic processing applications in biotech and pharmaceutical manufacturing operations. NovAseptic's products include a unique disposable sampling system (NovaSeptum(R)) and a range of high-performance mixers, valves, and connectors.
Most read news
Other news from the department business & finance
These products might interest you
2mag Magnetic Stirrers Catalogue 2024 by 2mag
Wear-free magnetic stirrers for laboratory and cell culture
Request the 2mag catalogue 2024 with innovative stirring solutions now
Flexsafe® Bag for Pro Mixer without top port - 1500 L by Sartorius
Efficient bioprocess optimisation: 1500 L Flexsafe® Pro Mixer Bag
Improved mixing processes and easy handling thanks to ergonomic design and inline sensors
Drive Units for Pro Mixer by Sartorius
Magnetic disposable agitator without surface contact perfect for biopharmaceutical process
Improved efficiency in cell harvesting and buffer preparation through advanced technology
YSTRAL Conti-TDS by ystral
YSTRAL Conti-TDS: The No. 1 in Powder Wetting
Induct, wet and disperse powder
Innovative Magnetic Stirrers by 2mag
Magnetic stirrer of the future - for laboratories and pilot plants
Individually configurable, 100 % wear-free, 3-year guarantee
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.